Taking T-Acute Lymphoblastic Leukemia (T-ALL) a ‘NOTCH’ higher (1/n): #AMPtutorials #AMPath24 #molpath
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.
A potential germline flag on a CGP report offers an opportunity for patients to uncover vital hereditary risk information, but only if there is appropriate follow-up, referral and testing.
If you missed the poster presentation at hashtag #AMPath24, read about the study here: bit.ly/4eNHZOM
Thank you #AMPath24 Program Cmte, all our exhibitors & sponsors, speakers, attendees, volunteers, and the @AMPath team for another truly amazing meeting. Thank you #Vancouver for being such a wonderful host city. Save the dates now for #AMPath25 Boston! #beantown
Shame there is no reimbursement of next generation cytogenetic technologies like OGM and others, tremendous clinical utility and versatility, and a viable answer to decreasing labor pool. #AMPath24
ICYMI my poster at #AMPath24, I'm sharing it here. Folks interested in long reads to resolve complex loci like repeat expansions relevant to neuro disease and carrier screening, check it out! @pacbio.bsky.social collab with @egor-dolzhenko.bsky.social @guilhermesena1.bsky.social and many others
Former #AMP president Laura Tafe is giving a fascinating and informative overview of her lab's experience bringing up whole exome and whole transcriptome tumor sequencing at #AMPATH24
Beginning to discuss the clinical bioinformatician’s role in a #Molecular lab in Rm 211 #AMPath24 @roysomak4 @sabahkadri Annette Leon Weiwei Zhang Ryan Schmidt
@AMPath Pres-elect Jane Gibson kicks off panel discussion about provider & patient-friendly molecular biomarker reporting #AMPath24 Rm 220
Attending #AMPath24? Head over to Room 214, Level 2 for our Corporate Workshop at 2pm PST. Visit Booth 1233 to meet the team! 👋
